Jalal Khoshnoodi Selected Research

Jalal Khoshnoodi Research Topics

Disease

16	Neoplasms (Cancer) 06/2023 - 12/2006
7	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2013
5	Infections 10/2021 - 10/2010
4	Hepatitis B 10/2021 - 09/2013
3	Whooping Cough (Pertussis) 01/2018 - 01/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2013 - 07/2008
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2011 - 01/2007
2	Leukemia 07/2011 - 02/2008
1	Lymphatic Metastasis 01/2023
1	COVID-19 12/2021
1	Chronic Hepatitis B 10/2021
1	Tetanus 03/2020
1	Infertility (Sterility) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2011
1	Atherosclerosis 03/2011
1	Epstein-Barr Virus Infections 09/2010
1	Hemophilia A (Haemophilia) 05/2009
1	Pathologic Processes 01/2007
1	Residual Neoplasm 01/2007
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 12/2021 - 01/2007
6	Monoclonal AntibodiesIBA 01/2023 - 07/2013
6	AntibodiesIBA 09/2022 - 05/2009
5	EpitopesIBA 06/2023 - 05/2009
5	Trastuzumab (Herceptin)FDA Link 02/2020 - 07/2013
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2018 - 01/2007
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 10/2010
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 10/2016
3	VaccinesIBA 01/2018 - 02/2016
3	Messenger RNA (mRNA)IBA 07/2011 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2013
2	human ERBB2 proteinIBA 11/2017 - 09/2017
2	hepatitis B hyperimmune globulinIBA 01/2017 - 10/2016
2	ThymidineIBA 01/2014 - 01/2003
2	Peptides (Polypeptides)IBA 01/2014 - 05/2009
2	EnzymesIBA 10/2010 - 01/2007
1	Tetanus ToxinIBA 06/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2021
1	Immunoglobulin M (IgM)IBA 12/2021
1	LigandsIBA 10/2021
1	Pattern Recognition ReceptorsIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	Poly I-CIBA 10/2021
1	NeurotoxinsIBA 03/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	CytokinesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	hersintuzumabIBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2018
1	Humanized Monoclonal AntibodiesIBA 01/2018
1	pertuzumabIBA 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 02/2016
1	Virulence Factors (Pathogenicity Factors)IBA 02/2016
1	Surface Antigens (Surface Antigen)IBA 10/2015
1	Neutralizing AntibodiesIBA 10/2015
1	tetanospasmin (tentoxilysin)IBA 01/2014
1	interleukin-21 (interleukin 21)IBA 06/2013
1	Pertussis VaccineIBA 01/2013
1	oxidized low density lipoproteinIBA 03/2011
1	ImmunosorbentsIBA 10/2010
1	CD40 Ligand (CD40L)IBA 09/2010
1	AutoantibodiesIBA 05/2009
1	Factor VIII (Coagulation Factor VIII)IBA 05/2009
1	Phosphotransferases (Kinase)IBA 01/2007
1	tyrosine receptor (receptor, tyrosine)IBA 01/2007
1	Coloring Agents (Dyes)IBA 01/2003
1	Neutral RedIBA 01/2003
1	Trypan Blue FDA Link 01/2003
1	T-2 Toxin (T 2 Toxin)IBA 01/2003

Therapy/Procedure

5	Immunotherapy 08/2018 - 12/2006
4	Therapeutics 10/2021 - 10/2016